1 – 10 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
(
- Contribution to journal › Article
-
Mark
Patient-derived models : Advanced tools for precision medicine in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Therapeutic strategies for high-risk neuroblastoma
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
(
- Contribution to journal › Article
-
Mark
The immune cell atlas of human neuroblastoma
(
- Contribution to journal › Article
- 2021
-
Mark
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research
2021) In Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 149. p.1-13(
- Contribution to journal › Article
-
Mark
Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma : What now?
(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
(
- Contribution to journal › Article
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article